TSVT实时信号 | 通过Getagraph.com最大化利润

购买 106833 min ago

@ $5.61

发出时间: 15 Feb 2024 @ 04:45

回报率: -24.15%

上一信号: Feb 15 - 02:38

上一信号: 出售

回报率: -2.09 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States...

Stats
今日成交量	311 142
平均成交量	1.46M
市值	218.33M
EPS	$0 ( 2024-03-05 )
下一个收益日期	( $-0.720 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.960
ATR14	$0.0110 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Snow Jessica	Buy	62 500	Stock Options (Right to buy)
2024-04-01	Snow Jessica	Buy	31 250	Common Stock
2024-04-01	Eatwell Victoria	Buy	42 500	Common Stock
2024-04-01	Eatwell Victoria	Buy	85 000	Stock Options (Right to buy)
2024-04-01	Baird William D Iii	Buy	56 250	Common Stock

INSIDER POWER
83.01
Last 92 transactions
Buy: 4 764 989 \| Sell: 362 997

音量相关性

長: 0.25 (neutral)

短: -0.17 (neutral)

Signal:(49.429) Neutral

2seventy bio, Inc. 相关性

10 最正相关
SLDP	0.89
HOOK	0.889
OBNK	0.877
MTEM	0.872
WKHS	0.871
STRS	0.854
LCID	0.851
SBNY	0.851
RBKB	0.849
METC	0.848

10 最负相关
VOR	-0.875
ACIW	-0.862
BNIXU	-0.855
BGNE	-0.839
AQMS	-0.835
FEMB	-0.822
FCBP	-0.807
NUTX	-0.806
MICT	-0.803
ITMR	-0.801

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

2seventy bio, Inc. 相关性 - 货币/商品

-0.16
( neutral )

-0.19
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.00
( neutral )

-0.48
( neutral )

2seventy bio, Inc. 财务报表

Annual	2023
营收:	$100.39M
毛利润:	$73.18M (72.90 %)
EPS:	$-4.42

FY	2023
营收:	$100.39M
毛利润:	$73.18M (72.90 %)
EPS:	$-4.42

FY	2022
营收:	$91.50M
毛利润:	$65.28M (71.34 %)
EPS:	$-7.13

FY	2021
营收:	$54 522.00
毛利润:	$52 005.00 (95.38 %)
EPS:	$-0.0126

Financial Reports:

No articles found.

2seventy bio, Inc.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

实时更新： 2seventy bio, Inc. [TSVT]

Upcoming Earnings Alert